Paris, France-based biotech company
Ermium Therapeutics has raised €6.3M across 1 funding round from 2 investors, most recently a round in Jul 2022. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-04 | Other |
| €6.3M |
| Fountain Healthcare Partners,Kurma Partners |
| View deal → |
